IDH1 and central nervous system cancer: One study recently reported successfully generating several IDH1 mutated glioma cell lines by growing them under serum-free conditions and selecting cells manually based on their tumor cell morphology and separating them physically from the non-tumor associated cells that are IDH-wildtype (127).